Brett H. Simmons

HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors

Farbod Shojaei, Joseph H. Lee, Brett H. Simmons et al. · Cancer Research · 2010 · 307 citations

Oncology, Angiogenesis, Endothelial Cells +15

Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies

Dana D. Hu‐Lowe, Enhong Chen, Lianglin Zhang et al. · Cancer Research · 2011 · 132 citations · Full text

Action Complementary, Immunology, Tumor Biology +16

Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer

Farbod Shojaei, Nathan Scott, Xiaolin Kang et al. · Journal of Experimental & Clinical Cancer Research · 2012 · 69 citations · Full text

Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia

Manoj Kumar Kashyap, Carlos I. Amaya-Chanaga, Deepak Kumar et al. · Journal of Hematology & Oncology · 2017 · 62 citations · Full text

HGF/c-Met pathway is one of the mediators of sunitinib-induced tumor cell type-dependent metastasis

Farbod Shojaei, Brett H. Simmons, Joseph H. Lee et al. · Cancer Letters · 2012 · 60 citations

Hgf/c-met Pathway, Oncology, Medicine +8